Company registration number 01746313 (England and Wales)
CHEMENCE LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
CHEMENCE LIMITED
COMPANY INFORMATION
Directors
C E Cooke
H V Cooke
V S Cooke
Company number
01746313
Registered office
6th Floor
Manfield House
1 Southampton Street
London
WC2R 0LR
Auditor
Alliotts LLP
Manfield House
1 Southampton Street
London
WC2R 0LR
CHEMENCE LIMITED
CONTENTS
Page
Strategic report
1 - 2
Directors' report
3 - 4
Independent auditor's report
5 - 7
Group statement of comprehensive income
8
Group balance sheet
9
Company balance sheet
10
Group statement of changes in equity
11
Company statement of changes in equity
12
Group statement of cash flows
13
Notes to the financial statements
14 - 35
CHEMENCE LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 1 -

The directors present the strategic report for the year ended 31 December 2024.

 

This Strategic Report has been prepared for Chemence Ltd and its subsidiaries, outlining matters deemed significant to management.

Review of the business

The directors report that the level of sales and after-tax profitability are satisfactory and that the business is continuing to manage its costs effectively.

Cash movements and general liquidity in the business continue to be understood and acceptable.

The directors remain satisfied regarding the year-end financial position of the company in respect of the achievement of identified KPI targets.

The global trading environment continues to be challenging and highly competitive at an industry level and the business uncertainty resulting from the global geopolitical situation and the increasing impact of climate change factors will continue to complicate this. The directors however remain confident that our overall trading position will improve further particularly in respect of developing our key domestic and export specialist businesses.

The company continues to build constructive, long-term partnerships with existing and potential customers. This is the key to its continued success. We are committed to long-term export-driven growth.

Principal risks and uncertainties

The key risks and uncertainties identified within the business are linked to broader concerns regarding the operation of the global economy, increasing political polarisation, tariffs and the management of inflationary pressures, sound economic planning and matters pertaining to the critical issues around climate change. The directors are fully satisfied that the company will continue to be able to respond positively to these challenges through innovation and planning.

The company continues to be driven by growth within all its markets however adverse currency movements continue to represent a key risk.

Consolidation within both the company’s supplier and customer network reflect the economic dynamic of globalisation. This continues to bring with it challenges for the company particularly in respect of managing its more mature markets. Any relative unwinding of globalisation will also present certain threats and opportunities for the business.

The company considers that the identified risks and uncertainties are mitigated through its network of close trading relationships within its key markets.

Development and performance

The directors expect the general level of activity and margins to improve in the coming year within the targeted higher margin customer markets. This is driven by the general pattern of activity during early- and mid-2025 and the continued positive support and feedback from customers, suppliers and other business stake-holders.

Company position at year-end

The directors are satisfied with the company’s financial and trading position at the 31st December 2024 and into 2025 and are also confident that this will be improved by continuing to leverage the development work already being undertaken within our targeted growth markets.

 

CHEMENCE LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 2 -
Key performance indicators

The directors consider the key performance indicators are those that communicate the financial performance, strength and willingness of the company to innovate and grow, typically; turnover, gross and net margin.

Turnover reduced during the 2024 from £10.5m to £9.4m. This was substantially compensated by an increase in gross margins from 38% to 45%, the reasons for this are understood and allowed for. The company’s net profit/(loss) before taxation has reduced slightly from £1.301m to £1.213m.

Business combinations

On 5 January 2024, Chemence Ltd acquired 100% of United Beauty Products Limited. The combination has been accounted as a merger in accordance with the FRS102 reporting standard.

The comparative figures have been restated to achieve uniformity of accounting policies.

 

On behalf of the board

C Cooke
Director
15 October 2025
CHEMENCE LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024
- 3 -

The directors present their annual report and financial statements for the year ended 31 December 2024.

Principal activities

Chemence is a primary manufacturer and distributor of high specification adhesives and solvents for the worldwide industrial, professional, medical and consumer markets, with production and modern, state-of-the-art packaging facilities. We additionally manufacture liquid photopolymer for use in flexographic printing and anaerobic and cementacious grouts for gas mains and service systems.

 

Chemence’s business foundations are built on strong innovation, technology and a global supply infrastructure, managed and maintained by a highly skilled workforce. Our primary objective is to provide chemical solutions and a level of service that surpass customer expectations. Considerable investment in research and development ensures Chemence chemistry remains at the forefront of technology. Our technical departments are responsible for ensuring that the needs of both new and existing customers are fully satisfied. Chemence recognises that quality is of the utmost importance and is accredited to the international standards ISO9001-2000 and QS9000.

Results and dividends

The results for the year are set out on page 8.

No ordinary dividends were paid. The directors do not recommend payment of a further dividend.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

H V Cooke
V S Cooke
C E Cooke
Research and development

The company continues to monitor all pertinent developments within the industry and continues to carry out its own product research and development.

Future developments

The company will continue to expand its business within selected markets. We will also leverage our position to develop new products and markets in line with our established strategy and focus on higher value-added sales. We wish to retain a strong competitive position by further improving business efficiencies, remaining flexible to meet and exceed the requirements of our customers and cultivating close working relationships throughout our customer and supply base.

Auditor

The auditor, Alliotts LLP, is deemed to be reappointed under section 487(2) of the Companies Act 2006.

CHEMENCE LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 4 -
Statement of directors' responsibilities

The directors are responsible for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the group and company, and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:

 

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the group’s and company’s transactions and disclose with reasonable accuracy at any time the financial position of the group and company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the group and company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the auditor of the company is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the auditor of the company is aware of that information.

Medium-sized companies exemption

This report has been prepared in accordance with the provisions applicable to companies entitled to the medium-sized companies exemption.

On behalf of the board
C Cooke
Director
15 October 2025
CHEMENCE LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF CHEMENCE LIMITED
- 5 -
Opinion

We have audited the financial statements of Chemence Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 December 2024 which comprise the group statement of comprehensive income, the group balance sheet, the company balance sheet, the group statement of changes in equity, the company statement of changes in equity, the group statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the group and parent company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

 

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

 

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

CHEMENCE LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF CHEMENCE LIMITED
- 6 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the group and the parent company and their environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.

 

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the parent company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

Extent to which the audit was considered capable of detecting irregularities, including fraud

Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows:

CHEMENCE LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF CHEMENCE LIMITED
- 7 -

We assessed the susceptibility of the company’s financial statements to material misstatement, including obtaining an understanding of how fraud might occur, by:

Audit response to risks identified

To address the risk of fraud through management bias and override of controls, we:

In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included, but were not limited to:

There are inherent limitations in our audit procedures described above. The more removed that laws and regulations are from financial transactions, the less likely it is that we would become aware of non-compliance. Auditing standards also limit the audit procedures required to identify non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any.

Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report

This report is made solely to the parent company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the parent company’s members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the parent company and the parent company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

Nicholas Nicolaou FCCA (Senior Statutory Auditor)
For and on behalf of Alliotts LLP, Statutory Auditor
Chartered Accountants
Manfield House
1 Southampton Street
London
WC2R 0LR
15 October 2025
CHEMENCE LIMITED
GROUP STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2024
- 8 -
2024
2023
as restated
Notes
£
£
Turnover
3
9,416,411
10,543,128
Cost of sales
(5,172,339)
(6,555,233)
Gross profit
4,244,072
3,987,895
Distribution costs
(857,637)
(827,682)
Administrative expenses
(2,413,389)
(2,087,185)
Other operating income
239,931
227,655
Profit before taxation
1,212,977
1,300,683
Tax on profit
9
(313,367)
(325,188)
Profit for the financial year
23
899,610
975,495
Other comprehensive income
Currency translation gain/(loss) taken to retained earnings
21,116
(70,487)
Total comprehensive income for the year
920,726
905,008
Profit for the financial year is all attributable to the owners of the parent company.
Total comprehensive income for the year is all attributable to the owners of the parent company.

The notes on pages 14 to 35 form part of these financial statements.

CHEMENCE LIMITED
GROUP BALANCE SHEET
AS AT
31 DECEMBER 2024
31 December 2024
- 9 -
2024
2023
as restated
Notes
£
£
£
£
Fixed assets
Tangible assets
11
2,027,823
2,116,343
Current assets
Stocks
14
2,090,140
1,913,591
Debtors
15
11,661,867
8,598,648
Cash at bank and in hand
877,006
264,165
14,629,013
10,776,404
Creditors: amounts falling due within one year
16
(8,146,742)
(5,271,811)
Net current assets
6,482,271
5,504,593
Total assets less current liabilities
8,510,094
7,620,936
Creditors: amounts falling due after more than one year
17
(682,193)
(715,935)
Provisions for liabilities
Deferred tax liability
19
15,934
13,760
(15,934)
(13,760)
Net assets
7,811,967
6,891,241
Capital and reserves
Called up share capital
21
100,000
100,000
Capital redemption reserve
22
16,667
16,667
Profit and loss reserves
23
7,695,300
6,774,574
Total equity
7,811,967
6,891,241

The notes on pages 14 to 35 form part of these financial statements.

These financial statements have been prepared in accordance with the provisions relating to medium-sized groups.

The financial statements were approved by the board of directors and authorised for issue on 15 October 2025 and are signed on its behalf by:
15 October 2025
C E Cooke
Director
Company registration number 01746313 (England and Wales)
CHEMENCE LIMITED
COMPANY BALANCE SHEET
AS AT 31 DECEMBER 2024
31 December 2024
- 10 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
11
98,820
103,158
Investments
12
119,907
119,907
218,727
223,065
Current assets
Stocks
14
1,944,752
1,746,422
Debtors
15
11,711,979
8,731,447
Cash at bank and in hand
785,268
226,865
14,441,999
10,704,734
Creditors: amounts falling due within one year
16
(8,066,522)
(5,241,096)
Net current assets
6,375,477
5,463,638
Total assets less current liabilities
6,594,204
5,686,703
Provisions for liabilities
Deferred tax liability
19
15,934
13,831
(15,934)
(13,831)
Net assets
6,578,270
5,672,872
Capital and reserves
Called up share capital
21
100,000
100,000
Capital redemption reserve
22
16,667
16,667
Profit and loss reserves
23
6,461,603
5,556,205
Total equity
6,578,270
5,672,872

The notes on pages 14 to 35 form part of these financial statements.

As permitted by section 408 of the Companies Act 2006, the company has not presented its own profit and loss account and related notes. The company’s profit for the year was £905,398 (2023 - £1,038,465 profit).

These financial statements have been prepared in accordance with the provisions relating to medium-sized companies.

The financial statements were approved by the board of directors and authorised for issue on 15 October 2025 and are signed on its behalf by:
15 October 2025
C Cooke
Director
Company registration number 01746313 (England and Wales)
CHEMENCE LIMITED
GROUP STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024
- 11 -
Share capital
Capital redemption reserve
Profit and loss reserves
Total
£
£
£
£
As restated for the period ended 31 December 2023:
Balance at 1 January 2023
100,000
16,667
4,517,743
4,634,410
Effect of restatements (note 31)
-
-
1,351,823
1,351,823
As restated
100,000
16,667
5,869,566
5,986,233
Year ended 31 December 2023:
Profit for the year
-
-
975,495
975,495
Other comprehensive income:
Currency translation differences
-
-
(70,487)
(70,487)
Total comprehensive income
-
-
905,008
905,008
Balance at 31 December 2023
100,000
16,667
6,774,574
6,891,241
Year ended 31 December 2024:
Profit for the year
-
-
899,610
899,610
Other comprehensive income:
Currency translation differences
-
-
21,116
21,116
Total comprehensive income
-
-
920,726
920,726
Balance at 31 December 2024
100,000
16,667
7,695,300
7,811,967

The notes on pages 14 to 35 form part of these financial statements.

CHEMENCE LIMITED
COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024
- 12 -
Share capital
Capital redemption reserve
Profit and loss reserves
Total
£
£
£
£
As restated for the period ended 31 December 2023:
Balance at 1 January 2023
100,000
16,667
4,517,743
4,634,410
Year ended 31 December 2023:
Profit and total comprehensive income for the year
-
-
1,038,462
1,038,462
Balance at 31 December 2023
100,000
16,667
5,556,205
5,672,872
Year ended 31 December 2024:
Profit and total comprehensive income
-
-
905,398
905,398
Balance at 31 December 2024
100,000
16,667
6,461,603
6,578,270

The notes on pages 14 to 35 form part of these financial statements.

CHEMENCE LIMITED
GROUP STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 13 -
2024
2023
as restated
Notes
£
£
£
£
Cash flows from operating activities
Cash generated from operations
28
954,850
314,856
Income taxes paid
(300,938)
(250,053)
Net cash inflow from operating activities
653,912
64,803
Investing activities
Purchase of tangible fixed assets
(39,677)
(767,585)
Purchase of investments
(11,742)
-
Proceeds from disposal of investments
11,742
-
Net cash used in investing activities
(39,677)
(767,585)
Financing activities
Proceeds from borrowings
-
715,935
Net cash generated from financing activities
-
715,935
Net increase in cash and cash equivalents
614,235
13,153
Cash and cash equivalents at beginning of year
264,165
251,012
Effect of foreign exchange rates
(1,394)
-
0
Cash and cash equivalents at end of year
877,006
264,165

The notes on pages 14 to 35 form part of these financial statements.

CHEMENCE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 14 -
1
Accounting policies
Company information

Chemence Limited (“the company”) is a private company limited by shares domiciled and incorporated in England and Wales. The registered office is 6th Floor, Manfield House, 1 Southampton Street, London, WC2R 0LR.

 

The principal place of business is 13 Princewood Road, Earlstrees Industrial Estate, Corby, Northamptonshire, England, NN17 4XD.

 

The group consists of Chemence Limited and all of its subsidiaries.

 

The principal activities of the group are disclosed in the directors' report.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

The company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements for parent company information presented within the consolidated financial statements:

 

CHEMENCE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 15 -
1.2
Business combinations

 

Business combinations other than group reconstructions

In the parent company financial statements, the cost of a business combination is the fair value at the acquisition date of the assets given, equity instruments issued and liabilities incurred or assumed, plus costs directly attributable to the business combination. The excess of the cost of a business combination over the fair value of the identifiable assets, liabilities and contingent liabilities acquired is recognised as goodwill. The cost of the combination includes the estimated amount of contingent consideration that is probable and can be measured reliably, and is adjusted for changes in contingent consideration after the acquisition date. Provisional fair values recognised for business combinations in previous periods are adjusted retrospectively for final fair values determined in the 12 months following the acquisition date. Investments in subsidiaries, joint ventures and associates are accounted for at cost less impairment.

 

Deferred tax is recognised on differences between the value of assets (other than goodwill) and liabilities recognised in a business combination accounted for using the purchase method and the amounts that can be deducted or assessed for tax, considering the manner in which the carrying amount of the asset or liability is expected to be recovered or settled. The deferred tax recognised is adjusted against goodwill or negative goodwill.

 

Group reconstructions

Business combinations that qualify as group reconstructions or combinations of entities under common control are accounted for using the merger accounting method. Under this method:

The policy is applied in accordance with relevant accounting standards FRS 102 Section 19, governing common control transactions.

1.3
Basis of consolidation

The consolidated group financial statements consist of the financial statements of the parent company Chemence Limited together with all entities controlled by the parent company (its subsidiaries), except where stated otherwise in note 13.

 

All financial statements are made up to 31 December 2024. Where necessary, adjustments are made to the financial statements of subsidiaries to bring the accounting policies used into line with those used by other members of the group.

 

All intra-group transactions, balances and unrealised gains on transactions between group companies are eliminated on consolidation. Unrealised losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred.

Subsidiaries are consolidated in the group’s financial statements from the date that control commences until the date that control ceases.

CHEMENCE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 16 -
1.4
Going concern

In adopting the going concern basis for preparing the financial statements the directors have considered the business activities as well as the company's principal risks and uncertainties within the company's cash flow forecasts and projections. This consideration includes the potential ongoing effects of global inflation and potential recession on the business.

 

The company has received a letter of support from group and connected companies which confirms that financial support will continue for a minimum of 12 months from the date of approval of the company's accounts, There is a cross-guarantee with the US related entities to recall the creditor balance only to the extent the group cannot recover the intercompany debtor balances. Therefore the directors consider the company will be able to meet its liabilities as they fall due and hence the financial statements are prepared on the going concern basis.

1.5
Turnover

Turnover relates primarily to the sales of adhesives, liquid photopolymer and the sale of cosmetic products and is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Rental income is recognised on a straight-line basis over the period to which it relates. Any rent incentives are spread evenly over the relevant term and recognised as an adjustment to rental income, in accordance with FRS 102.

1.6
Research and development expenditure

Research expenditure is written off against profits in the year in which it is incurred. Identifiable development expenditure is capitalised to the extent that the technical, commercial and financial feasibility can be demonstrated.

1.7
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

 

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Patents & licences
20% on cost
1.8
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

CHEMENCE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 17 -

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Freehold land and buildings
2% - 2.5% straight line
Leasehold improvements
20% on cost
Plant and equipment
33% on cost of computers, 20% on cost for all other plant and equipment
Fixtures and fittings
20% on cost
Motor vehicles
25% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the profit and loss account.

The company has elected to classify investment properties rented to other group companies as tangible fixed assets.

1.9
Fixed asset investments

In the parent company financial statements, investments in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the group. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

1.10
Impairment of fixed assets

At each reporting period end date, the group reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

 

The carrying amount of the investments accounted for using the equity method is tested for impairment as a single asset. Any goodwill included in the carrying amount of the investment is not tested separately for impairment.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

CHEMENCE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 18 -
1.11
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.12
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.13
Financial instruments

The group has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the group's balance sheet when the group becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset and the net amounts presented in the financial statements when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

 

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the group transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

CHEMENCE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 19 -
Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the group after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, and loans from fellow group companies, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Derecognition of financial liabilities

Financial liabilities are derecognised when the group's contractual obligations expire or are discharged or cancelled.

1.14
Equity instruments

Equity instruments issued by the group are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the group.

1.15
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The group’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset if, and only if, there is a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

CHEMENCE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 20 -
1.16
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

 

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.17
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.18
Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

 

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leased asset are consumed.

Rental income from operating leases is recognised on a straight line basis over the term of the relevant lease. Initial direct costs incurred in negotiating and arranging an operating lease are added to the carrying amount of the leased asset and recognised on a straight line basis over the lease term.

1.19
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

CHEMENCE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 21 -
2
Judgements and key sources of estimation uncertainty

In the application of the group’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Critical judgements
Inventories

Inventories are valued at the lower of cost and net realisable value. Net realisable value includes, where necessary, provisions for slow moving and obsolete stocks. Calculation of these provisions requires judgements to be made, which include forecast consumer demand, the promotional, competitive and economic environment and inventory loss trends.

Intercompany receivables recovery

Judgement is required to determine whether there are indicators of impairment of the company’s intercompany receivable balances. Factors taken into consideration in reaching such a decision include the economic viability, group support and expected future financial performance of the various entities.

Key sources of estimation uncertainty
Inventory provisioning

When considering the inventory provision, management considers the nature and condition of the inventory, as well as applying assumptions around anticipated saleability of inventory held and recent sales performance of inventory lines.

Inventory overhead absorption

When considering the inventory overhead absorption provision, management estimate the overhead and labour element per unit. The estimate is based upon standard costing for employee time and a pro-rated overheads which are regularly reviewed by management to ensure that the calculation remains reliable as costs alter.

3
Turnover
2024
2023
£
£
Turnover analysed by class of business
Distribution of adhesives and liquid photopolymer
8,983,435
10,120,653
Distribution of cosmetic products
360,829
422,475
Rental Income
72,147
-
9,416,411
10,543,128
CHEMENCE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
3
Turnover
(Continued)
- 22 -
2024
2023
£
£
Turnover analysed by geographical market
United Kingdom
5,093,309
5,054,145
European Community
2,684,473
3,181,574
Rest of World
1,638,629
2,307,409
9,416,411
10,543,128
4
Other operating income

Other operating income relates to fees receivable in respect of management services provided by the directors and other employees of the group.

5
Operating profit
2024
2023
£
£
Operating profit for the year is stated after charging/(crediting):
Exchange gains
(59,437)
(85,160)
Research and development costs
12,802
12,810
Depreciation of owned tangible fixed assets
116,965
105,327
Operating lease charges
58,246
60,590
6
Auditor's remuneration
2024
2023
Fees payable to the company's auditor and associates:
£
£
For audit services
Audit of the financial statements of the group and company
32,200
12,500
Audit of the financial statements of the company's subsidiaries
-
5,100
32,200
17,600
For other services
Other taxation services
5,280
5,100
All other non-audit services
3,710
2,796
8,990
7,896
CHEMENCE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 23 -
7
Employees

The average monthly number of persons (including directors) employed by the group and company during the year was:

Group
Company
2024
2023
2024
2023
Number
Number
Number
Number
Production
29
27
27
24
Selling and Distribution and Administration
34
34
31
31
Total
63
61
58
55

Their aggregate remuneration comprised:

Group
Company
2024
2023
2024
2023
£
£
£
£
Wages and salaries
2,066,420
1,961,077
2,004,748
1,871,418
Social security costs
223,907
223,036
224,518
219,593
Pension costs
72,939
72,028
72,229
70,272
2,363,266
2,256,141
2,301,495
2,161,283
8
Directors' remuneration
2024
2023
£
£
Remuneration for qualifying services
149,725
149,725
Company pension contributions to defined contribution schemes
4,657
3,823
154,382
153,548

There are no key management personnel other than the directors.

9
Taxation
2024
2023
£
£
Current tax
UK corporation tax on profits for the current period
307,878
313,409
Foreign current tax on profits for the current period
3,012
-
0
Total current tax
310,890
313,409
CHEMENCE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
9
Taxation
2024
2023
£
£
(Continued)
- 24 -
Deferred tax
Origination and reversal of timing differences
2,477
11,779
Total tax charge
313,367
325,188

The actual charge for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:

2024
2023
£
£
Profit before taxation
1,212,977
1,300,683
Expected tax charge based on the standard rate of corporation tax in the UK of 25.00% (2023: 23.52%)
303,244
305,921
Tax effect of expenses that are not deductible in determining taxable profit
906
7,752
Deferred tax adjustments in respect of prior years
-
0
1,370
Foreign exchange differences
(851)
-
0
Remeasurement of deferred tax for changes in tax rates
-
0
615
Fixed asset differences
10,068
9,616
Marginal relief
-
0
(86)
Taxation charge
313,367
325,188
10
Intangible fixed assets
Group
Goodwill
Patents & licences
Total
£
£
£
Cost
At 1 January 2024 and 31 December 2024
233,999
28,676
262,675
Amortisation and impairment
At 1 January 2024 and 31 December 2024
233,999
28,676
262,675
Carrying amount
At 31 December 2024
-
0
-
0
-
0
At 31 December 2023
-
0
-
0
-
0
The company had no intangible fixed assets at 31 December 2024 or 31 December 2023.
CHEMENCE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 25 -
11
Tangible fixed assets
Group
Freehold land and buildings
Leasehold improvements
Plant and equipment
Fixtures and fittings
Motor vehicles
Total
£
£
£
£
£
£
Cost
At 1 January 2024 as restated
4,103,177
-
0
6,441,835
102,966
52,211
10,700,189
Additions
-
0
5,295
34,382
-
0
-
0
39,677
Exchange adjustments
23,665
-
0
-
0
-
0
-
0
23,665
At 31 December 2024
4,126,842
5,295
6,476,217
102,966
52,211
10,763,531
Depreciation and impairment
At 1 January 2024 as restated
2,089,992
-
0
6,340,232
102,966
50,656
8,583,846
Depreciation charged in the year
72,950
971
41,878
-
0
1,166
116,965
Exchange adjustments
34,897
-
0
-
0
-
0
-
0
34,897
At 31 December 2024
2,197,839
971
6,382,110
102,966
51,822
8,735,708
Carrying amount
At 31 December 2024
1,929,003
4,324
94,107
-
0
389
2,027,823
At 31 December 2023 as restated
2,013,185
-
0
101,603
-
0
1,555
2,116,343
Company
Leasehold improvements
Plant and equipment
Motor vehicles
Total
£
£
£
£
Cost
At 1 January 2024
-
0
6,263,981
52,211
6,316,192
Additions
5,295
34,382
-
0
39,677
At 31 December 2024
5,295
6,298,363
52,211
6,355,869
Depreciation and impairment
At 1 January 2024
-
0
6,162,378
50,656
6,213,034
Depreciation charged in the year
971
41,878
1,166
44,015
At 31 December 2024
971
6,204,256
51,822
6,257,049
Carrying amount
At 31 December 2024
4,324
94,107
389
98,820
At 31 December 2023
-
0
101,603
1,555
103,158

The freehold land and buildings relates to the carrying value of investment properties rented to other group companies and treated as tangible fixed assets.

CHEMENCE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 26 -
12
Fixed asset investments
Group
Company
2024
2023
2024
2023
Notes
£
£
£
£
Investments in subsidiaries
13
-
0
-
0
119,907
119,907
Movements in fixed asset investments
Company
Shares in subsidiaries
£
Cost or valuation
At 1 January 2024 and 31 December 2024
119,907
Carrying amount
At 31 December 2024
119,907
At 31 December 2023
119,907
13
Subsidiaries

Details of the company's subsidiaries at 31 December 2024 are as follows:

Name of undertaking
Registered office
Class of
% Held
shares held
Direct
Allied Chemical, Inc
1338 Coronet Drive, Dalton, GA 30720 USA
Ordinary
100.00
Gibnas Trade SL
Carrer de Montilla, 5-7, 08970, Sant Joan Despi, Barcelona, Spain
Ordinary
100.00
United Beauty Products
6th Floor, Manfield House, 1 Southampton Street, London, England, WC2R 0LR
Ordinary
100.00
-

Chemence Limited will guarantee the debts and liabilities of United Beauty Products Limited which is claiming the statutory audit exemption at the balance sheet date in accordance with Section 479C of the Companies Act 2006. The Company has assessed the probability of loss under the guarantee as remote.

14
Stocks
Group
Company
2024
2023
2024
2023
£
£
£
£
Raw materials and consumables
1,187,378
1,199,600
1,187,378
1,199,600
Finished goods and goods for resale
902,762
713,991
757,374
546,822
2,090,140
1,913,591
1,944,752
1,746,422
CHEMENCE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 27 -
15
Debtors
Group
Company
2024
2023
2024
2023
Amounts falling due within one year:
£
£
£
£
Trade debtors
447,000
734,400
376,143
678,223
Amounts owed by group undertakings
11,079,230
7,703,949
11,248,917
7,916,902
Other debtors
23,633
44,552
1,338
44,049
Prepayments and accrued income
110,623
114,063
85,581
92,273
11,660,486
8,596,964
11,711,979
8,731,447
Deferred tax asset (note 19)
1,381
1,684
-
0
-
0
11,661,867
8,598,648
11,711,979
8,731,447

Amounts owed by group undertakings are unsecured, interest free and repayable on demand.

16
Creditors: amounts falling due within one year
Group
Company
2024
2023
2024
2023
£
£
£
£
Trade creditors
660,531
676,851
642,272
659,979
Amounts owed to group undertakings
7,080,006
4,165,115
7,038,876
4,161,280
Corporation tax payable
224,811
214,859
217,837
211,856
Other taxation and social security
53,422
73,542
46,383
68,955
Other creditors
817
817
-
0
-
0
Accruals and deferred income
127,155
140,627
121,154
139,026
8,146,742
5,271,811
8,066,522
5,241,096

Amounts owed to group undertakings are unsecured, interest free and repayable on demand.

17
Creditors: amounts falling due after more than one year
Group
Company
2024
2023
2024
2023
Notes
£
£
£
£
Other borrowings
18
682,193
715,935
-
0
-
0
CHEMENCE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 28 -
18
Loans and overdrafts
Group
Company
2024
2023
2024
2023
£
£
£
£
Loans from group undertakings
682,193
715,935
-
0
-
0
Payable after one year
682,193
715,935
-
0
-
0

Loans from fellow group undertakings relate to a EUR 825,000 unsecured loan provided by a fellow group company in January 2023. Interest is charged at a rate of 0.25% above the European Central Bank rate and is payable quarterly. The agreement includes a one year moratorium on repayments of interest, with the first payment due on 31 March 2024. The principal is payable at the maturity date of 31 December 2032.

19
Deferred taxation

The following are the major deferred tax liabilities and assets recognised by the group and company, and movements thereon:

Liabilities
Liabilities
Assets
Assets
2024
2023
2024
2023
Group
£
£
£
£
(Decelerated)/accelerated capital allowances
(321)
(1,725)
1,381
1,684
Tax losses
16,255
15,485
-
-
15,934
13,760
1,381
1,684
Liabilities
Liabilities
Assets
Assets
2024
2023
2024
2023
Company
£
£
£
£
(Decelerated)/accelerated capital allowances
(321)
(1,654)
-
-
Tax losses
16,255
15,485
-
-
15,934
13,831
-
-
Group
Company
2024
2024
Movements in the year:
£
£
Liability at 1 January 2024
12,076
13,831
Charge to profit or loss
2,477
2,103
Liability at 31 December 2024
14,553
15,934
CHEMENCE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
19
Deferred taxation
(Continued)
- 29 -

The deferred tax liability set out above is expected to reverse within 12 months and relates to accelerated capital allowances that are expected to mature within the same period.

20
Retirement benefit schemes
2024
2023
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
72,939
72,028

A defined contribution pension scheme is operated for all qualifying employees. The assets of the scheme are held separately from those of the group in an independently administered fund. Amounts payable in respect of pensions at the reporting date were £14,435 (2023: £15,387).

21
Share capital
Group and company
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
100,000
100,000
100,000
100,000

The company has one class of ordinary shares which carry no right to fixed income. Each share carries one voting right.

22
Capital redemption reserve

The capital redemption reserve is a statutory, non-distributable reserve into which amounts are transferred following the redemption or purchase of a company's own shares out of distributable profits or, in certain circumstances, from the proceeds of a fresh issue of shares.

23
Profit and loss reserves

Profit and loss account: includes all current and prior period retained profit and losses.

CHEMENCE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 30 -
24
Financial commitments, guarantees and contingent liabilities

The company and its subsidiaries are party to a Composite Accounting Agreement with its bankers which provides cross guarantees for borrowing provided to its fellow subsidiaries, along with other connected companies. At 31 December 2024 the total potential amount outstanding under the guarantee amounted to £nil (2023: £nil).

 

The company has a contingent liability in relation to a guarantee provided to Primarius Properties Limited. Chemence Limited has guaranteed the balance on a director's loan of £nil (2023: £2,417,832) and is liable to reimburse Primarius Properties Limited in the case of default.

 

The Company also provided a guarantee of £160,000 (2023: £160,000) to HMRC.

 

As described in note 13, Chemence Limited will guarantee the £38,781 of debts and liabilities of United Beauty Products Limited which is claiming the statutory audit exemption at the balance sheet date in accordance with Section 479C of the Companies Act 2006. The company has assessed the probability of loss under the guarantee as remote.

 

A subsidiary company in the group has a commitment to carry out certain monitoring activities with respect to contaminated land. All such costs are incurred by other group companies with no obligation for the subsidiary company to make repayment. Consequently, no provision has been recognised in the financial statements.

25
Operating lease commitments
Lessee

Operating lease payments represent rentals payable by the company for certain of its properties and car leases. Property leases are negotiated for an average term of 10 years and rentals are fixed for an average of 3 years.

At the reporting end date the group had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:

Group
Company
2024
2023
2024
2023
£
£
£
£
Within one year
480,000
37,500
480,000
37,500
Between two and five years
1,920,000
-
1,920,000
-
In over five years
1,960,000
-
1,960,000
-
4,360,000
37,500
4,360,000
37,500
CHEMENCE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
25
Operating lease commitments
(Continued)
- 31 -
Lessor

The operating leases represent the lease of property in Gibnas Trade S.L. to a related entity. The leases are negotiated over terms of 3 years and rentals are fixed for 3 years.

At the reporting end date the group had contracted with tenants for the following minimum lease payments:

Group
Company
2024
2023
2024
2023
£
£
£
£
Within one year
71,947
72,147
-
-
Between two and five years
-
71,947
-
-
71,947
144,094
-
-
26
Related party transactions

The following amounts were outstanding at the reporting end date:

Amounts due to related parties
2024
2023
£
£
Group
Other related parties
7,080,006
4,165,115
Company
Other related parties
7,038,876
4,161,280

The following amounts were outstanding at the reporting end date:

Amounts due from related parties
2024
2023
Balance
Balance
£
£
Group
Other related parties
11,079,230
7,703,949
Company
Other related parties
11,248,917
7,916,902
Other information

The company has taken advantage of the exemption available in Paragraph 33.1A of FRS102 whereby it has not disclosed transactions with other companies that are wholly owned within the Group.

CHEMENCE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 32 -
27
Controlling party

The parent company is Chemence Trading Limited, a company registered in Hong Kong with registered office of 12/F, Two Chinachem Plaza, 68 Connaught Road Central, Hong Kong

 

No one person has overall control.

28
Cash generated from group operations
2024
2023
£
£
Profit after taxation
899,610
975,495
Adjustments for:
Taxation charged
313,367
325,188
Depreciation and impairment of tangible fixed assets
116,965
105,327
Movements in working capital:
Increase in stocks
(176,549)
(104,276)
Increase in debtors
(3,063,522)
(2,617,137)
Increase in creditors
2,864,979
1,630,259
Cash generated from operations
954,850
314,856
29
Analysis of changes in net funds/(debt) - group
1 January 2024
Cash flows
Exchange rate movements
31 December 2024
£
£
£
£
Cash at bank and in hand
264,165
614,235
(1,394)
877,006
Borrowings excluding overdrafts
(715,935)
-
33,742
(682,193)
(451,770)
614,235
32,348
194,813
CHEMENCE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 33 -
30
Prior period adjustment
Changes to the balance sheet - group
As previously reported
Adjustment at 1 Jan 2023
Adjustment at 31 Dec 2023
As restated at 31 Dec 2023
£
£
£
£
Fixed assets
Tangible assets
785,981
1,442,270
(111,908)
2,116,343
Investments
113,658
(113,658)
-
-
899,639
1,328,612
(111,908)
2,116,343
Current assets
Stocks
1,746,422
172,534
(5,365)
1,913,591
Deferred tax asset
-
3,255
(1,571)
1,684
Debtors due within one year
8,731,851
(120,483)
(14,403)
8,596,965
Bank and cash
235,129
1,144
27,892
264,165
10,713,402
56,450
6,553
10,776,405
Creditors due within one year
Taxation
(281,100)
(7,642)
341
(288,401)
Trade and other creditors
(4,960,285)
(25,597)
2,471
(4,983,411)
5,241,385
33,239
(2,812)
5,271,812
Creditors due after one year
Loans and overdrafts
(715,935)
-
-
(715,935)
715,935
-
-
715,935
Provisions for liabilities
Deferred tax
(13,760)
-
-
(13,760)
13,760
-
-
13,760
Net assets
5,641,961
1,351,823
(102,543)
6,891,241
Capital and reserves
Share capital
100,000
-
0
-
100,000
Capital redemption
16,667
-
0
-
16,667
Profit and loss reserves
5,525,294
1,351,823
(102,543)
6,774,574
Total equity
5,641,961
1,351,823
(102,543)
6,891,241
CHEMENCE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
30
Prior period adjustment
(Continued)
- 34 -
Changes to the profit and loss account - group
As previously reported
Adjustment
As restated
Period ended 31 December 2023
£
£
£
Turnover
10,142,877
400,251
10,543,128
Cost of sales
(6,345,380)
(209,853)
(6,555,233)
Gross profit
3,797,497
190,398
3,987,895
Distribution costs
(827,682)
-
(827,682)
Administrative expenses
(1,869,305)
(217,880)
(2,087,185)
Other operating income
227,655
-
227,655
Profit before taxation
1,328,165
(27,482)
1,300,683
Taxation
(320,614)
(4,574)
(325,188)
Profit after taxation
1,007,551
(32,056)
975,495
Reconciliation of changes in equity - group
1 January
31 December
2023
2023
£
£
Adjustments to prior year
Acquisition of United Beauty Products Limited - merger accounting
23,212
32,577
Consolidation of Allied Chemical, Inc
1,328,611
1,216,703
Total adjustments
1,351,823
1,249,280
Equity as previously reported
4,634,410
5,641,961
Equity as adjusted
5,986,233
6,891,241
Analysis of the effect upon equity
Profit and loss reserves
1,351,823
1,249,280
CHEMENCE LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
30
Prior period adjustment
(Continued)
- 35 -
Reconciliation of changes in profit for the previous financial period
2023
£
Adjustments to prior year
Acquisition of United Beauty Products Limited - merger accounting
9,365
Consolidation of Allied Chemical, Inc
(41,421)
Total adjustments
(32,056)
Profit as previously reported
1,007,551
Profit as adjusted
975,495
Notes to reconciliation
Acquisition of United Beauty Products Limited - merger accounting

During the financial year ended 31 December 2024, the Group completed a group reconstruction by acquiring the entire share capital of United Beauty Products Limited through a stock transfer on 5 January 2024, at a consideration of £1 for £1 of share capital. The combination has been accounted for using the merger accounting method in accordance with FRS 102. Comparative figures have been restated to ensure consistency and uniformity of accounting policies across the group.

Consolidation of Allied Chemical, Inc

During the year ended 31 December 2024, it was identified that subsidiary company Allied Chemical, Inc had been omitted from the consolidated accounts. A restatement has therefore been recognised to consolidate this entity as at 1 January 2023 and 31 December 2023.

2024-12-312024-01-01falsefalseCCH SoftwareCCH Accounts Production 2025.200H CookeV CookeC Cookefalse01746313bus:Consolidated2024-01-012024-12-31017463132024-01-012024-12-3101746313bus:RegisteredOffice2024-01-012024-12-3101746313bus:Director32024-01-012024-12-31017463132024-12-3101746313bus:Consolidated2024-12-3101746313bus:Consolidated2023-01-012023-12-31017463132023-01-012023-12-3101746313core:RetainedEarningsAccumulatedLossesbus:Consolidated2024-01-012024-12-3101746313core:RetainedEarningsAccumulatedLossesbus:Consolidated2023-01-012023-12-3101746313bus:Consolidated2023-12-31017463132023-12-3101746313core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2024-12-3101746313core:LeaseholdImprovementsbus:Consolidated2024-12-3101746313core:PlantMachinerybus:Consolidated2024-12-3101746313core:FurnitureFittingsbus:Consolidated2024-12-3101746313core:MotorVehiclesbus:Consolidated2024-12-3101746313core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2023-12-3101746313core:LeaseholdImprovementsbus:Consolidated2023-12-3101746313core:PlantMachinerybus:Consolidated2023-12-3101746313core:FurnitureFittingsbus:Consolidated2023-12-3101746313core:MotorVehiclesbus:Consolidated2023-12-3101746313core:LeaseholdImprovements2024-12-3101746313core:PlantMachinery2024-12-3101746313core:MotorVehicles2024-12-3101746313core:LeaseholdImprovements2023-12-3101746313core:PlantMachinery2023-12-3101746313core:MotorVehicles2023-12-3101746313core:ShareCapitalbus:Consolidated2024-12-3101746313core:ShareCapitalbus:Consolidated2023-12-3101746313core:CapitalRedemptionReservebus:Consolidated2024-12-3101746313core:CapitalRedemptionReservebus:Consolidated2023-12-3101746313core:RetainedEarningsAccumulatedLossesbus:Consolidated2024-12-3101746313core:RetainedEarningsAccumulatedLossesbus:Consolidated2023-12-3101746313core:ShareCapital2024-12-3101746313core:ShareCapital2023-12-3101746313core:CapitalRedemptionReserve2024-12-3101746313core:CapitalRedemptionReserve2023-12-3101746313core:RetainedEarningsAccumulatedLosses2024-12-3101746313core:RetainedEarningsAccumulatedLosses2023-12-3101746313core:ShareCapitalbus:Consolidated2022-12-3101746313core:CapitalRedemptionReservebus:Consolidated2022-12-31017463132022-12-3101746313core:ShareCapital2022-12-3101746313core:CapitalRedemptionReserve2022-12-3101746313core:RetainedEarningsAccumulatedLosses2022-12-3101746313core:ShareCapitalbus:Consolidatedcore:AccountingPolicyChangeIncreaseDecrease2022-12-3101746313core:CapitalRedemptionReservebus:Consolidatedcore:AccountingPolicyChangeIncreaseDecrease2022-12-3101746313bus:Consolidated2022-12-3101746313core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3101746313core:PatentsTrademarksLicencesConcessionsSimilar2024-01-012024-12-3101746313core:LandBuildingscore:OwnedOrFreeholdAssets2024-01-012024-12-3101746313core:LeaseholdImprovements2024-01-012024-12-3101746313core:PlantMachinery2024-01-012024-12-3101746313core:FurnitureFittings2024-01-012024-12-3101746313core:MotorVehicles2024-01-012024-12-3101746313core:UKTaxbus:Consolidated2024-01-012024-12-3101746313core:UKTaxbus:Consolidated2023-01-012023-12-3101746313core:ForeignTaxbus:Consolidated2024-01-012024-12-3101746313core:ForeignTaxbus:Consolidated2023-01-012023-12-3101746313bus:Consolidated12024-01-012024-12-3101746313bus:Consolidated12023-01-012023-12-3101746313bus:Consolidated22024-01-012024-12-3101746313bus:Consolidated22023-01-012023-12-3101746313bus:Consolidated32024-01-012024-12-3101746313bus:Consolidated32023-01-012023-12-3101746313bus:Consolidated42024-01-012024-12-3101746313bus:Consolidated42023-01-012023-12-3101746313core:Goodwillbus:Consolidated2023-12-3101746313core:PatentsTrademarksLicencesConcessionsSimilarbus:Consolidated2023-12-3101746313bus:Consolidated2023-12-3101746313core:Goodwillbus:Consolidated2024-12-3101746313core:PatentsTrademarksLicencesConcessionsSimilarbus:Consolidated2024-12-3101746313core:Goodwillbus:Consolidated2023-12-3101746313core:PatentsTrademarksLicencesConcessionsSimilarbus:Consolidated2023-12-3101746313core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2023-12-3101746313core:LeaseholdImprovementsbus:Consolidated2023-12-3101746313core:PlantMachinerybus:Consolidated2023-12-3101746313core:FurnitureFittingsbus:Consolidated2023-12-3101746313core:MotorVehiclesbus:Consolidated2023-12-3101746313core:LeaseholdImprovements2023-12-3101746313core:PlantMachinery2023-12-3101746313core:MotorVehicles2023-12-31017463132023-12-3101746313core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2024-01-012024-12-3101746313core:LeaseholdImprovementsbus:Consolidated2024-01-012024-12-3101746313core:PlantMachinerybus:Consolidated2024-01-012024-12-3101746313core:FurnitureFittingsbus:Consolidated2024-01-012024-12-3101746313core:MotorVehiclesbus:Consolidated2024-01-012024-12-3101746313core:Subsidiary12024-01-012024-12-3101746313core:Subsidiary22024-01-012024-12-3101746313core:Subsidiary32024-01-012024-12-3101746313core:Subsidiary112024-01-012024-12-3101746313core:Subsidiary222024-01-012024-12-3101746313core:Subsidiary332024-01-012024-12-3101746313core:CurrentFinancialInstruments2024-12-3101746313core:CurrentFinancialInstruments2023-12-3101746313core:CurrentFinancialInstrumentsbus:Consolidated2024-12-3101746313core:CurrentFinancialInstrumentsbus:Consolidated2023-12-3101746313core:CurrentFinancialInstrumentscore:WithinOneYearbus:Consolidated2024-12-3101746313core:CurrentFinancialInstrumentscore:WithinOneYearbus:Consolidated2023-12-3101746313core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3101746313core:CurrentFinancialInstrumentscore:WithinOneYear2023-12-3101746313core:Non-currentFinancialInstrumentsbus:Consolidated2024-12-3101746313core:Non-currentFinancialInstrumentsbus:Consolidated2023-12-3101746313core:Non-currentFinancialInstruments2024-12-3101746313core:Non-currentFinancialInstruments2023-12-3101746313core:Non-currentFinancialInstrumentscore:AfterOneYearbus:Consolidated2024-12-3101746313core:Non-currentFinancialInstrumentscore:AfterOneYearbus:Consolidated2023-12-3101746313core:Non-currentFinancialInstrumentscore:AfterOneYear2024-12-3101746313core:Non-currentFinancialInstrumentscore:AfterOneYear2023-12-3101746313bus:PrivateLimitedCompanyLtd2024-01-012024-12-3101746313bus:FRS1022024-01-012024-12-3101746313bus:Audited2024-01-012024-12-3101746313bus:ConsolidatedGroupCompanyAccounts2024-01-012024-12-3101746313bus:Director12024-01-012024-12-3101746313bus:Director22024-01-012024-12-3101746313bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP